• HanAll Biopharma Reports Second Quarter 2021 Results prnasia
    July 29, 2021
    HanAll Biopharma announced today that the company had achieved sales of 23.4 billion won, operating profit of 1.6 billion won, and net profit of 3.3 billion won in the second quarter of 2021.
PharmaSources Customer Service